Initial National Cancer Institute studies on mutagenesis as a prescreen for chemical carcinogens: an appraisal

Area of Science:

• Toxicology
• Genetics
• Microbiology

Background:

• Carcinogen detection is crucial for public health and safety.
• Numerous in vitro and in vivo assays exist for evaluating potential carcinogens.
• Standardized and sensitive screening methods are needed for routine assessment.

Purpose of the Study:

• To evaluate the efficacy of various in vitro and in vivo assays in detecting known organic carcinogens.
• To identify the most effective assay systems for carcinogen prescreening.

Main Methods:

• Assessed the performance of multiple carcinogen detection assays, including bacterial and mammalian cell-based systems.
• Utilized Salmonella typhimurium and polymerase A-deficient Escherichia coli for in vitro testing.
• Included assays such as L5178y cell resistance, Saccharomyces cerevisiae D3, host-mediated assay, and DNA repair (thymidine uptake).

Main Results:

• Salmonella and polymerase A-deficient Escherichia coli in vitro systems showed the highest detection rates.
• These two bacterial assays collectively identified 82% of the organic carcinogens tested.
• Other evaluated systems were considered less sensitive for routine prescreening.

Conclusions:

• Bacterial assays, specifically Salmonella and E. coli, are highly effective for detecting organic carcinogens.
• These systems offer a robust and efficient approach for the prescreening of potential carcinogenic compounds.
• Further development may be needed for other tested assays to reach sufficient sensitivity for routine screening.